Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Treasury Shares: 2021-2024

Historic Treasury Shares for Krystal Biotech (KRYS) over the last 4 years, with Dec 2024 value amounting to $308,096.

  • Krystal Biotech's Treasury Shares rose 6.64% to $330,092 in Q3 2025 from the same period last year, while for Sep 2025 it was $330,092, marking a year-over-year increase of 6.64%. This contributed to the annual value of $308,096 for FY2024, which is 91.48% up from last year.
  • Latest data reveals that Krystal Biotech reported Treasury Shares of $308,096 as of FY2024, which was up 91.48% from $160,900 recorded in FY2023.
  • Krystal Biotech's Treasury Shares' 5-year high stood at $308,096 during FY2024, with a 5-year trough of $66,600 in FY2022.
  • Its 3-year average for Treasury Shares is $178,532, with a median of $160,900 in 2023.
  • As far as peak fluctuations go, Krystal Biotech's Treasury Shares crashed by 32.59% in 2022, and later skyrocketed by 141.59% in 2023.
  • Krystal Biotech's Treasury Shares (Yearly) stood at $98,800 in 2021, then plummeted by 32.59% to $66,600 in 2022, then surged by 141.59% to $160,900 in 2023, then skyrocketed by 91.48% to $308,096 in 2024.